Diagnostic accuracy of the faecal immunochemical test for colorectal cancer in symptomatic patients: Comparison with NICE and SIGN referral criteria

Colorectal Disease

Volumn 16, Issue 8, 2014, Pages

  Cubiella, J ^a   Salve, M ^a   Diaz Ondina M ^a   Vega, P ^a   Alves, M T ^b   Iglesias, F ^c   Sanchez E ^a   Macia P ^a   Blanco, I ^a   Bujanda, L ^d   Fernandez Seara J ^a  

^a Department of Gastroenterology Complexo Hospitalario Universitario de Ourense ^*  (Spain)

^b Research Support Unit   (Spain)

^c UNIVERSITY HOSPITAL COMPLEX OF VIGO   (Spain)

^d HOSPITAL DONOSTIA   (Spain)

Author keywords

Colonoscopy; Colorectal cancer; Diagnostic accuracy; Fecal immunochemical test; Risk stratification

Indexed keywords

ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER TEST; COLONOSCOPY; COLORECTAL CANCER; COMPARATIVE EFFECTIVENESS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FECAL IMMUNOCHEMICAL TEST; FECES ANALYSIS; FEMALE; HUMAN; IMMUNOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MCNEMAR TEST; MULTICENTER STUDY; NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE REFERRAL CRITERIA; PATIENT REFERRAL; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCOTTISH INTERCOLLEGIATE GUIDELINES NETWORK REFERRAL CRITERIA; SENSITIVITY AND SPECIFICITY; SINGLE BLIND PROCEDURE; SPAIN; CHEMISTRY; CLINICAL TRIAL; COLORECTAL NEOPLASMS; COMPARATIVE STUDY; DIAGNOSTIC TEST; EARLY DIAGNOSIS; FECES; MIDDLE AGED; PREDICTIVE VALUE; PROCEDURES; RISK; VERY ELDERLY;

TUMOR MARKER;

ADULT; AGED; AGED, 80 AND OVER; COLONOSCOPY; COLORECTAL NEOPLASMS; DIAGNOSTIC TESTS, ROUTINE; EARLY DETECTION OF CANCER; FECES; FEMALE; HUMANS; IMMUNOCHEMISTRY; MALE; MIDDLE AGED; ODDS RATIO; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; REFERRAL AND CONSULTATION; SENSITIVITY AND SPECIFICITY; SINGLE-BLIND METHOD; SPAIN; TUMOR MARKERS, BIOLOGICAL;

EID: 84904405784     PISSN: 14628910     EISSN: 14631318     Source Type: Journal    
DOI: 10.1111/codi.12569     Document Type: Article

References (30)

1. Ferlay J, Shin HR, Bray F, Foreman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010; 127: 2893-917.
2. Lozano R, Naghavi M, Foreman K et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380: 2095-128.
3. Lansdorp-Vogelaar I, Knudsen AB, Brenner H. Cost-effectiveness of colorectal cancer screening. Epidemiol Rev 2011; 33: 88-100.
4. Zauber AG, Knudsen AB, Rutter CM et al. Cost-Effectiveness of CT Colonography to Screen for Colorectal Cancer. Technology Assessment Report, Project ID CTCC0608: 2009; 1-92. http://www.ahrq.gov/clinic/ta/tadctcc/ (accessed August 2013).
5. Scottish Intercollegiate Guidelines Network (SIGN). Diagnosis and Management of Colorectal Cancer, SIGN publication no. 126. Edinburgh: SIGN, 2011. December. http://www.sign.ac.uk. (accessed August 2013).
6. NICE Clinical Guideline 27. (2011) Referral Guidelines for Suspected Cancer, April. www.nice.org.uk/CG027 (accessed August 2013).
7. Selvachandran SN, Hodder RJ, Ballal MS, Jones P, Cade D. Prediction of colorectal cancer by a patient consultation questionnaire and scoring system: a prospective study. Lancet 2002; 360: 278-83.
8. Adelstein BA, Macaskill P, Turner RM, Katelaris PH, Irwig L. The value of age and medical history for predicting colorectal cancer and adenomas in people referred for colonoscopy. BMC Gastroenterol 2011; 11: 97.
9. Hippisley-Cox J, Coupland C. Identifying patients with suspected colorectal cancer in primary care: derivation and validation of an algorithm. Br J Gen Pract 2012; 62: e29-37.
10. Referral Guidelines for Suspected Cancer. http://nww.doh.nhsweb.nhs.uk/cancer (Accessed August 2013).
11. Zafar A, Mak T, Whinnie S, Chapman MA. The 2-week wait referral system does not improve 5-year colorectal cancer survival. Colorectal Dis 2012; 14: e177-80.
12. Rai S, Kelly MJ. Prioritization of colorectal referrals: a review of the 2-week wait referral system. Colorectal Dis 2007; 9: 195-202.
13. Chohan DP, Goodwin K, Wilkinson S, Miller R, Hall NR. How has the 'two-week wait' rule affected the presentation of colorectal cancer? Colorectal Dis 2005; 7: 450-3.
14. Jellema P, van der Windt DA, Bruinvels DJ et al. Value of symptoms and additional diagnostic tests for colorectal cancer in primary care: systematic review and meta-analysis. BMJ 2010; 340: c1269.
15. Thorne K, Hutchings HA, Elwyn G. The effects of the two-week rule on NHS colorectal cancer diagnostic services: a systematic literature review. BMC Health Serv Res 2006; 6: 43.
16. Shabbir J, Vijayan V, Silavant M, Fowler AL, Cook TA, Lucarotti ME. Two week rule referral for patients with colorectal cancer below the age of 50; are we being ageist? Surgeon 2009; 5: 276-81.
17. Harrison AJ, Foot CS. Targets and prioritization: the case of cancer in the English NHS. Qual Prim Care 2012; 20: 125-9.
18. Quintero E, Castells A, Bujanda L et al. Colonoscopy versus fecal immunochemical testing in colorectal-cancer screening. N Eng J Med 2012; 366: 697-706.
19. Levi Z, Rozen P, Hazazi R et al. A quantitative immunochemical fecal occult blood test for colorectal neoplasia. Ann Intern Med 2007; 146: 244-55.
20. McDonald PJ, Digby J, Innes C et al. Low fecal haemoglobin concentration potentially rules out significant colorectal disease. Colorectal Dis 2013; 15: e151-9.
21. Oono Y, Iriguchi Y, Doi Y et al. A retrospective study of immunochemical fecal occult blood testing for colorectal cancer detection. Clin Chim Acta 2010; 411: 802-5.
22. Adelstein BA, Irwig L, Macaskill P, Katelaris PH, Jones DB, Bokey L. A self administered reliable questionnaire to assess lower bowel symptoms. BMC Gastroenterol 2008; 8: 8.
23. Jover R, Herráiz M, Alarcón O et al. Clinical practice guidelines: quality of colonoscopy in colorectal cancer screening. Endoscopy 2012; 44: 444-51.
24. Edge A, Byrd SB, Compton DR, Fritz CC, Greene AG, Trotti FL (eds). AJCC Cancer Staging Manual, 7th edition. Berlin: Springer, 2010.
25. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating curves: a nonparametric approach. Biometrics 1988; 44: 837-45.
26. von Elm E, Altman DG, Egger M et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol 2008; 61: 344-9.
27. Bossuyt PM, Reitsma JB, Bruns DE et al. Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. Fam Pract 2004; 21: 4-10.
28. Gillberg A, Ericsson E, Granstrom F, Olsson LI. A population-based audit of the clinical use of fecal occult blood testing in primary care for colorectal cancer. Colorectal Dis 2012; 14: e539-46.
29. Salas D. Situacion de los Programas de Cribado de Cáncer Colorrectal en España. (2012). http://www.programascancerdemama.org/index.php/situacion-de-los-programas-de-cribado-de-cancer-colorrectal-en-espana-ano-2012 (accessed 25 March 2013).
30. Haug U, Knudsen AB, Brenner H, Kuntz KM. Is fecal occult blood testing more sensitive for left- versus right-sided colorectal neoplasia? A systematic literature review. Expert Rev Mol Diagn 2011; 11: 605-16.